Harvest Portfolios Group Inc. (“Harvest”) is proud to announce that the Harvest Healthcare Leaders Income ETF (HHL:TSX) “HHL” ...
2025 was a tumultuous year for the global healthcare sector. For much of the year, policy uncertainty, particularly around U.S. drug pricing and trade barriers, weighed heavily on valuations, which ...
Healthcare stocks have lagged the market for years, but 2026 is looking much better.
The health care industry is facing headwinds, but analysts continue to forecast growth in 2026. In a Jan. 12 report, consulting firm McKinsey found that the U.S. health care system is under increased ...
Wall Street was downbeat last week. The S&P 500 index lost 1.95%, the Dow Jones index retreated 1.9% and the Nasdaq Composite slumped 2.7%. Overvaluation concerns in the artificial intelligence (AI) ...
The Trump administration has sent shockwaves through the healthcare sector by proposing nearly flat reimbursement rates for Medicare Advantage (MA) plans for 2027. Announced on Jan. 26, 2026, the ...
The current generation of deals, which is likely to involve AbbVie (NYSE: ABBV), Merck & Co Inc (NYSE: MRK), Bristol-Myers Squibb Co (NYSE: BMY), and Gilead Sciences Inc (NYSE: GILD), is focused on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results